# Neo Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neo-medical

- Industry: Medical Devices & Equipment
- Headquarters: Switzerland
- Website: www.neo-medical.com
- Total disclosed funding: $68M
- Latest round: Series B (Sep 17, 2024)
- Investors on record: 1

## About

Founded in 2013 by Co-CEOs, Jonas Larsson and Vincent Lefauconnier, and based in Villette, Switzerland, Neo Medical SA operates as a developer of medical devices that help surgeons prevent implant loosening during spinal surgeries. In September 2024, Neo Medical SA raised CHF 58 million in Series B funding led by Gyrus Capital, with participation from other investors. The company's management also participated in the round.

Neo Medical offers a comprehensive platform called Neo Universal™ for spinal surgery, aimed at optimizing healthcare by improving surgical outcomes, streamlining treatment, and minimizing environmental impacts. The company also operates the Spine Expert Network for Science & Education (SENSE), facilitating global knowledge exchange among spine surgeons on the latest advancements in degenerative and trauma/tumor surgery. Neo Medical develops technologies, including Controlled Fixation for biomechanical control during surgery, and specializes in AI-supported augmented reality for spinal fusion procedures. 

The company intends to use the September 2024 funding to expand its US business, deploy new products, and enhance its AI-driven augmented reality data platform, advise.

## Funding rounds

- Series B, Sep 17, 2024, $68M — Gyrus Capital

## Investors

- Gyrus Capital (https://capitalatlas.ai/funds/gyrus-capital) — Series B